Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Hyllengren Eric J. Officer active across 1 company, notably Atara Biotherapeutics, Inc.. In total, 11 disclosures have been published. Split: 0 buy · 9 sells. Total volume traded: €72k. Activity tracked since 16 May 2023. The latest transaction was disclosed on 3 March 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations11 total
1,211 shares@ US$6.99711.3% of flowCommon StockSEC:0000905148-25-000864:0
34,050 shares0Common StockSEC:0000905148-25-000245:0
1,364 shares@ US$11.19820.1% of flowCommon StockSEC:0000905148-24-003242:0
29 shares@ US$6.6310.2% of flowCommon StockSEC:0000905148-24-002303:1
1,041 shares@ US$6.6298.7% of flowCommon StockSEC:0000905148-24-002303:0
28,648 shares@ US$0.61722.6% of flowCommon StockSEC:0000905148-24-001558:0
1,462 shares@ US$0.7211.4% of flowCommon StockSEC:0000905148-24-000908:0
475,000 shares0Common StockSEC:0000905148-24-000112:0
11,958 shares@ US$0.3896.0% of flowCommon StockSEC:0000905148-23-001509:0
6,408 shares@ US$1.65213.5% of flowCommon StockSEC:0001140361-23-040564:0
6,199 shares@ US$2.03716.1% of flowCommon StockSEC:0001140361-23-025558:0